VG Life Sciences, Inc.
1321 Mountain View Circle
Azusa
California
91702
United States
Tel: 626-334-5310
Fax: 626-334-5324
Website: http://www.viralgenetics.com/
Email: info@viralgenetics.com
101 articles about VG Life Sciences, Inc.
-
VG Life Sciences, Inc. Notes Major Achievements And New Grants In Third Quarter 2015
10/8/2015
-
VG Life Sciences, Inc. Granted Combination Cancer Drug Patent
6/22/2015
-
VG Life Sciences, Inc. Granted Key Composition Of Matter Patent
3/2/2015
-
VG Life Sciences, Inc. Announces Issuance Of Patent Covering Treatment Of Inflammatory Bowel Disease With Clip-Inducing Agent
1/29/2015
-
VG Life Sciences, Inc. Q4 2014 Shareholder Update Letter
1/15/2015
-
VG Life Sciences, Inc. Release: New Data Implicate Components Of Adaptive Immunity In Traumatic Brain Injury
10/20/2014
-
VG Life Sciences, Inc. Announces SEC Form 10 Review Complete
10/15/2014
-
VG Life Sciences, Inc.' Advisor Gives Preeclampsia Presentation At American Heart Association Conference
9/12/2014
-
VG Life Sciences, Inc. Progress Update Phase I Cancer Study
9/4/2014
-
VG Life Sciences, Inc. Announces Filing Of Form 10 With The SEC
6/24/2014
-
VG Life Sciences, Inc. Release: Q1 2014 Shareholder Update Letter
5/13/2014
-
VG Life Sciences, Inc. Moves To Restore Financial Accountability & Completes Prior Year Audits, Plans To File Form 10
5/1/2014
-
VG Life Sciences, Inc. Reports On Clinical Outcomes In Phase I Cancer Study
3/17/2014
-
VG Life Sciences, Inc. Reports On Clinical Outcomes In Phase 1 Cancer Study
3/14/2014
-
VG Life Sciences, Inc. Increases Authorized Shares
1/3/2014
-
VG Life Sciences, Inc. December 2013 Shareholder Letter
12/18/2013
-
VG Life Sciences, Inc. Update On Phase I Cancer Study
12/13/2013
-
VG Life Sciences, Inc. Announces the Initiation of IND-Enabling Animal Safety Studies
11/4/2013
-
U.S. Patent Office Issues Patent for VG Life Sciences, Inc.' Peptide for HIV Treatment
10/31/2013
-
VG Life Sciences, Inc. Starts Prior Year Audit to Increase Financial Accountability
10/17/2013